Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
UKALL60+ is a trial for acute lymphoblastic leukemia (ALL) that aims to identify a standard of care for patients over the age of 60 yrs. David Marks, MD, PhD, from the University Hospitals Bristol NHS Foundation Trust, Bristol, UK, talks to us about the aims of the trial. Recorded at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.